Genitourinary tract changes

Obstetrics and Gynecology

Volumn 104, Issue 4 SUPPL., 2004, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ESTROGEN THERAPY; FEMALE; HUMAN; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; URINARY TRACT INFECTION; URINE INCONTINENCE; VAGINA DISEASE;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; URINARY INCONTINENCE; URINARY TRACT INFECTIONS; VAGINAL DISEASES;

EID: 16544383560     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000138800.95463.cc     Document Type: Article

References (53)

1. Rizk DE, Raaschou T, Mason N., Berg B. Evidence of progesterone receptors in the mucosa of the urinary bladder. Scand J Urol Nephrol 2001; 35: 305-9. (Level II-2) (Pubitemid 32906853)
2. Copas P, Bukovsky A, Asbury B., Elder RF, Caudle MR Estrogen, progesterone, and androgen receptor expression in levator ani muscle and fascia. J Womens Health Gend Based Med 2001; 10: 785-95. (Level II-2) (Pubitemid 33062088)
3. Dennerstein L, Dudley EC, Hopper J.L., Guthrie JR, Burger HG A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000; 96: 351-8. (Level II-2)
4. Stadberg E, Mattsson LA, Milsom I. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand 1997; 76: 442-8. (Level II-3) (Pubitemid 27226266)
5. Stenberg A, Heimer G, Ulmsten U., Cnattingius S. Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas 1996; 24: 31-6. (Level III) (Pubitemid 26180101)
6. Molander U, Arvidsson L, Milsom I., Sandberg T. A longitudinal cohort study of elderly women with urinary tract infections. Maturitas 2000; 34: 127-31. (Level II-2) (Pubitemid 30068651)
7. Samsioe G, Heraib F, Lidfeldt J., Nerbrand C, Lindhom L, Agardh C., et al. Urogenital symptoms in women age 50-59 years. Women's Health in Lund Area (WHILSA) Study Group. Gynecol Endocrinol 1999; 13: 113-7. (Level II-2) (Pubitemid 29273901)
8. Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984; 63: 257-60. (Level III) (Pubitemid 14149172)
9. Samuelsson EC, Victor FT, Svardsudd KF Five-year incidence and remission rates of female urinary incontinence ina Swedish population less than 65years old. AmJ Obstet Gynecol 2000; 183: 568-74. (Level II-2)
10. Brown JS, Grady D, Ouslander J.G., Herzog AR, Varner RE, Posner SF Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 1999; 94: 66-70. (Level I) (Pubitemid 29284428)
11. Larson B, Collins A, Landgren BM Urogenital and vaso-motor symptoms in relation to menopausal status and the use of hormone replacement therapy (HRT) in healthy women during transition to menopause. Maturitas 1997; 28: 99-105. (Level II-2) (Pubitemid 28085895)
12. Utian WH, Shoupe D, Bachmann G., Pinkerton JV, Pickar JH Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001; 75: 1065-79. (Level I) (Pubitemid 32522600)
13. Notelovitz M, Mattox JH Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estra-diol. Menopause 2000; 7: 310-7. (Level I)
14. van der Linden MC, Gerretsen G, Brandhorst M.S., Ooms EC, Kremer CM, Doesburg WH The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms. Eur J Obstet Gynecol Reprod Biol 1993; 51: 29-33. (Level I) (Pubitemid 23340889)
15. Manonai J, Theppisai U, Suthutvoravut S., Udomsubpayakul U, Chittacharoen A. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study. J Obstet Gynaecol Res 2001; 27: 255-60. (Level I) (Pubitemid 33121175)
16. Rioux JE, Devlin C, Gelfand M.M., Steinberg WM, Hepburn DS 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atro-phic vaginitis. Menopause 2000; 7: 156-61. (Level I) (Pubitemid 30249896)
17. Dugal R, Hesla K, Sordal T., Aase KH, Lilleeidet O, Wickstrom E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000; 79: 293-7. (Level I) (Pubitemid 30156501)
18. Ayton RA, Darling GM, Murkies A.L., Farrell EA, Weisberg E, Selinus I, et al A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol 1996; 103: 351-8. (Level I) (Pubitemid 26106031)
19. Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 1997; 71: 73-80. (Level II-3) (Pubitemid 27045856)
20. Chompootaweep S, Nunthapisud P, Trivijitsilp P., Sentrakul P, Dusitsin N. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in post-menopausal Thai women: a comparative study. Clin Pharmacol Ther 1998; 64: 204-10. (Level I) (Pubitemid 28423856)
21. Padwick ML, Siddle NC, Lane G, Endacott J.A., Cooper H., Pryse-Davies J, et al. Oestriol with oestradiol versus oes-tradiol alone: a comparison of endometrial, symptomatic, and psychological effects. Br J Obstet Gynaecol 1986; 93: 606-12. (Level II-3) (Pubitemid 16094096)
22. Notelovitz M, Funk S, Nanavati N., Mazzeo M. Estradiol absorption from vaginal tablets in postmenopausal women. Obstet Gynecol 2002; 99: 556-62. (Level I) (Pubitemid 34246288)
23. Nilsson K, Heimer G. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency-a pharmacoki-netic and pharmacodynamic study. Maturitas 1992; 15: 121-7. (Level I)
24. Handa VL, Bachus KE, Johnston W.W., Robboy SJ, Hammond CB Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endome-trium. Obstet Gynecol 1994; 84: 215-8. (Level II-3) (Pubitemid 24234828)
25. Grady D, Brown JS, Vittinghoff E, Applegate W., Varner E, Snyder T. Postmenopausal hormones and incontinence. The Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001; 97: 116-20. (Level I)
26. Jackson S, Shepherd A, Brookes S., Abrams P. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol 1999; 106: 711-8. (Level I) (Pubitemid 29304395)
27. Fantl JA, Bump RC, Robinson D, McClish D.K., Wyman JF Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group. Obstet Gynecol 1996; 88: 745-9. (Level I) (Pubitemid 26360811)
28. Cardozo L, Rekers H, Tapp A., Barnick C, Shepherd A, Schussler B., et al. Oestriol in the treatment of postmeno-pausal urgency: a multicentre study. Maturitas 1993; 18: 47-53. (Level I) (Pubitemid 24037142)
29. Wilson PD, Faragher B, Butler B., Bu'Lock D, Robinson EL, Brown AD. Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmeno-pausal women. Br J Obstet Gynaecol 1987; 94: 568-74. (Level I) (Pubitemid 17077768)
30. Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG 2000; 107: 1029-34. (Level I) (Pubitemid 30495461)
31. Ishiko O, Hirai K, Sumi T., Tatsuta I, Ogita S. Hormone replacement therapy plus pelvic floor muscle exercise for postmenopausal stress incontinence: a randomized controlled trial. J Reprod Med 2001; 46: 213-20. (Level I) (Pubitemid 32298400)
32. Brown JS, Vittinghoff E, Kanaya A.M., Agarwal SK, Hulley S, Foxman B. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Heart and Estrogen/Progestin Replacement Study Research Group. Obstet Gynecol 2001; 98: 1045-52. (Level I) (Pubitemid 34075329)
33. Cardozo L, Benness C, Abbott D. Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol 1998; 105: 403-7. (Level I) (Pubitemid 28237866)
34. Kirkengen AL, Andersen P, Gjersoe E., Johannessen GR, Johnsen N, Bodd E. Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. Scand J Prim Health Care 1992; 10: 139-42. (Level I)
35. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmeno-pausal women. Am J Obstet Gynecol 1999; 180: 1072-9. (Level I) (Pubitemid 29258997)
36. Raz R, Stamm WE A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753-6. (Level I) (Pubitemid 23262529)
37. Cardozo L, Lose G, McClish D., Versi E, de Konihg Gans H. A systematic review of estrogens for recurrent urinary tract infections: third report of the Hormones and Urogenital Therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12: 15-20. (Meta-analysis) (Pubitemid 32219739)
38. Oliveria SA, Klein RA, Reed J.I., Cirillo PA, Christos PJ, Walker AM Estrogen replacement therapy and urinary tract infections in postmenopausal women aged 45-89. Menopause 1998; 5: 4-8. (Level II-2) (Pubitemid 28257380)
39. Orlander JD, Jick SS, Dean A.D., Jick H. Urinary tract infections and estrogen use in older women. J Am Geriatr Soc 1992; 40: 817-20. (Level II-2)
40. Rigg LA, Hermann H, Yen SS Absorption of estrogens from vaginal creams. N Engl J Med 1978; 298: 195-7. (Level III) (Pubitemid 8272278)
41. Horwitz RI, Feinstein AR Intravaginal estrogen creams and endometrial cancer: no causal association found. JAMA 1979; 241: 1266-7. (Level II-2) (Pubitemid 9222057)
42. Weiderpass E, Baron JA, Adami H.O., Magnusson C., Lindgren A, Bergstrom R, et al Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet 1999; 353: 1824-8. (Level II-2) (Pubitemid 29251013)
43. Miodrag A, Ekelund P, Burton R., Castleden CM Tamox-ifen and partial oestrogen agonism in postmenopausal women. Age Ageing 1991; 20: 52-4. (Level II-2)
44. Fisher B, Costantino JP, Wickerham D.L., Redmond CK, Kavanah M, Cronin WM, et al Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90: 1371-88. (Level I) (Pubitemid 28439961)
45. Bruning PF. Droloxifene, a new anti-oestrogen in post-menopausal advanced breast cancer: preliminary results of a double-blind dose-finding phase II trial. Eur J Cancer 1992; 28 A:1404-7. (Level I)
46. Vardy MD, Lindsay R, Scotti R.J., Mikhail M., Richart RM, Nieves J, et al. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol 2003; 189: 81-8. (Level I) (Pubitemid 36886529)
47. Davies GC, Huster WJ, Lu Y, Plouffe L Jr, Lakshmanan M. Adverse events reported by postmenopausal women in controlled trials with raloxifene. Obstet Gynecol 1999; 93: 558-65. (Level III) (Pubitemid 29147076)
48. Waetjen LE, Brown JS, Modelska K, Blackwell T., Vittinghoff E, Cummings SR Effect of raloxifene on urinary incontinence: a randomized controlled trial. MORE Study Group. Obstet Gynecol 2004; 103: 261-6. (Level I)
49. Parsons A, Merritt D, Rosen A., Health H 3rd, Siddhanti S, Plouffe L Jr. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in post-menopausal vaginal atrophy. Study Groups on the Effects of Raloxifene HCI with Low-Dose Premarin Vaginal Cream. Obstet Gynecol 2003; 101: 346-52. (Level I) (Pubitemid 36170137)
50. Pinkerton JV. Shifren JL, LaValleur J, Rosen A, Roesinger M, Siddhanti S. Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in post-menopausal women. Menopause 2003; 10: 45-52. (Level I) (Pubitemid 36706321)
51. Wilcox G, Wahlqvist ML, Burger H.G., Medley G. Oestro-genic effects of plant foods in postmenopausal women. BMJ 1990; 301: 905-6. (Level II-2) (Pubitemid 20355341)
52. Baird DD, Umbach DM, Lansdell L, Hughes C.L., Setchell KD, Weinberg CR, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995; 80: 1685-90. (Level I)
53. Bygdeman M, Swahn ML Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 1996; 23: 259-63. (Level I) (Pubitemid 26000605)